Exploratory Clinical Study to Evaluation of the Safety and Immunogenicity of Bivalent Vaccine V-01D-351
Clinical trial NCT05583357 · UNKNOWN
Trial details
- NCT number
- NCT05583357
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-15
- Primary completion
- 2022-09-13
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.